PortfoliosLab logoPortfoliosLab logo
NGNE vs. JXN
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

NGNE vs. JXN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Neurogene Inc (NGNE) and Jackson Financial Inc. (JXN). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

NGNE vs. JXN - Yearly Performance Comparison


2026 (YTD)20252024202320222021
NGNE
Neurogene Inc
5.15%-9.89%17.96%90.37%-89.44%-40.20%
JXN
Jackson Financial Inc.
-0.85%26.93%76.45%57.22%-11.54%34.86%

Fundamentals

EPS

NGNE:

-$4.70

JXN:

$0.34

Total Revenue (TTM)

NGNE:

$0.00

JXN:

$6.58B

Gross Profit (TTM)

NGNE:

-$787.00K

JXN:

$1.24B

EBITDA (TTM)

NGNE:

-$90.05M

JXN:

$319.00M

Returns By Period

In the year-to-date period, NGNE achieves a 5.15% return, which is significantly higher than JXN's -0.85% return.


NGNE

1D
7.44%
1M
4.44%
YTD
5.15%
6M
20.50%
1Y
124.34%
3Y*
15.66%
5Y*
-38.77%
10Y*
-19.60%

JXN

1D
-0.84%
1M
-5.44%
YTD
-0.85%
6M
5.29%
1Y
28.44%
3Y*
47.31%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NGNE vs. JXN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NGNE
NGNE Risk / Return Rank: 7474
Overall Rank
NGNE Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
NGNE Sortino Ratio Rank: 8181
Sortino Ratio Rank
NGNE Omega Ratio Rank: 7474
Omega Ratio Rank
NGNE Calmar Ratio Rank: 7171
Calmar Ratio Rank
NGNE Martin Ratio Rank: 6666
Martin Ratio Rank

JXN
JXN Risk / Return Rank: 6666
Overall Rank
JXN Sharpe Ratio Rank: 6767
Sharpe Ratio Rank
JXN Sortino Ratio Rank: 5959
Sortino Ratio Rank
JXN Omega Ratio Rank: 6060
Omega Ratio Rank
JXN Calmar Ratio Rank: 7070
Calmar Ratio Rank
JXN Martin Ratio Rank: 7272
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NGNE vs. JXN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Neurogene Inc (NGNE) and Jackson Financial Inc. (JXN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NGNEJXNDifference

Sharpe ratio

Return per unit of total volatility

1.19

0.78

+0.41

Sortino ratio

Return per unit of downside risk

2.25

1.17

+1.08

Omega ratio

Gain probability vs. loss probability

1.25

1.17

+0.09

Calmar ratio

Return relative to maximum drawdown

1.62

1.53

+0.09

Martin ratio

Return relative to average drawdown

3.00

4.06

-1.06

NGNE vs. JXN - Sharpe Ratio Comparison

The current NGNE Sharpe Ratio is 1.19, which is higher than the JXN Sharpe Ratio of 0.78. The chart below compares the historical Sharpe Ratios of NGNE and JXN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


NGNEJXNDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.19

0.78

+0.41

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.42

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.22

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.11

0.83

-0.94

Correlation

The correlation between NGNE and JXN is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

NGNE vs. JXN - Dividend Comparison

NGNE has not paid dividends to shareholders, while JXN's dividend yield for the trailing twelve months is around 3.15%.


TTM20252024202320222021
NGNE
Neurogene Inc
0.00%0.00%0.00%0.00%0.00%0.00%
JXN
Jackson Financial Inc.
3.15%3.00%3.22%4.84%6.32%1.20%

Drawdowns

NGNE vs. JXN - Drawdown Comparison

The maximum NGNE drawdown since its inception was -98.34%, which is greater than JXN's maximum drawdown of -48.34%. Use the drawdown chart below to compare losses from any high point for NGNE and JXN.


Loading graphics...

Drawdown Indicators


NGNEJXNDifference

Max Drawdown

Largest peak-to-trough decline

-98.34%

-48.34%

-50.00%

Max Drawdown (1Y)

Largest decline over 1 year

-52.37%

-19.30%

-33.07%

Max Drawdown (5Y)

Largest decline over 5 years

-97.20%

Max Drawdown (10Y)

Largest decline over 10 years

-98.14%

Current Drawdown

Current decline from peak

-95.11%

-13.48%

-81.63%

Average Drawdown

Average peak-to-trough decline

-67.41%

-15.29%

-52.12%

Ulcer Index

Depth and duration of drawdowns from previous peaks

28.28%

7.27%

+21.01%

Volatility

NGNE vs. JXN - Volatility Comparison

Neurogene Inc (NGNE) has a higher volatility of 22.64% compared to Jackson Financial Inc. (JXN) at 8.63%. This indicates that NGNE's price experiences larger fluctuations and is considered to be riskier than JXN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


NGNEJXNDifference

Volatility (1M)

Calculated over the trailing 1-month period

22.64%

8.63%

+14.01%

Volatility (6M)

Calculated over the trailing 6-month period

66.66%

22.55%

+44.11%

Volatility (1Y)

Calculated over the trailing 1-year period

106.97%

36.79%

+70.18%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

93.03%

44.35%

+48.68%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

87.47%

44.35%

+43.12%

Financials

NGNE vs. JXN - Financials Comparison

This section allows you to compare key financial metrics between Neurogene Inc and Jackson Financial Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober0
1.99B
(NGNE) Total Revenue
(JXN) Total Revenue
Values in USD except per share items